Papillary thyroid carcinoma
|
0.330 |
Biomarker
|
disease |
BEFREE |
Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.
|
15876154 |
2005 |
Papillary thyroid carcinoma
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
Differential expression of multiple isoforms of the ELKS mRNAs involved in a papillary thyroid carcinoma.
|
12203787 |
2002 |
Papillary thyroid carcinoma
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
The ELKS-RET gene fusion rearrangement we had observed in a papillary thyroid carcinoma occurred between intron 10 of the ELKS gene and intron 11 of RET.
|
10697956 |
2000 |
Papillary thyroid carcinoma
|
0.330 |
FusionGene
|
disease |
ORPHANET |
Fusion of a novel gene, ELKS, to RET due to translocation t(10;12)(q11;p13) in a papillary thyroid carcinoma.
|
10337992 |
1999 |
Distal monosomy 12p
|
0.300 |
ChromosomalRearrangement
|
disease |
ORPHANET |
12p13.33 microdeletion including ELKS/ERC1, a new locus associated with childhood apraxia of speech.
|
22713806 |
2013 |
Leukemia, Myelocytic, Acute
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.
|
27903959 |
2017 |
Leukemia, Myelocytic, Acute
|
0.110 |
Biomarker
|
disease |
LHGDN |
A PDGFRB-positive acute myeloid malignancy with a new t(5;12)(q33;p13.3) involving the ERC1 gene.
|
17690697 |
2008 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Vital capacity
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Body Height
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Evaluation and application of summary statistic imputation to discover new height-associated loci.
|
29782485 |
2018 |
Tumor Cell Invasion
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The scaffold protein ERC1/ELKS and its partners promote cell migration and invasion, and assemble into dynamic networks at the protruding edge of cells.
|
31537859 |
2019 |
Varicosity
|
0.010 |
Biomarker
|
disease |
BEFREE |
Using super resolution microscopy, we identified co-clustering of the active zone scaffolding proteins bassoon, RIM and ELKS in ∼30% of dopamine varicosities.
|
29398114 |
2018 |
Sore to touch
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
The present results suggest that meat tenderness in Nellore cattle does not directly depend on the expression of the CAPN1 and CAPN2 genes, but is associated with the expression of other genes such as CAST2, HSP90AA1, DNAJA1 and HSPB1.
|
29331838 |
2018 |
Complete hydatidiform mole
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Whole-exome sequencing reveals genetic variants in ERC1 and KCNG4 associated with complete hydatidiform mole in Chinese Han women.
|
29088863 |
2017 |
Autism Spectrum Disorders
|
0.010 |
Biomarker
|
disease |
BEFREE |
All previous cases reported with partial monosomy of 12p13.33 are associated with neurodevelopmental delay, and we suggest that ERC1, which encodes a regulator of neurotransmitter release, is the best gene candidate contributing to this phenotype as well as to the ASD of our patient.
|
24613754 |
2014 |
Apraxia, Developmental Verbal
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
12p13.33 microdeletion including ELKS/ERC1, a new locus associated with childhood apraxia of speech.
|
22713806 |
2013 |
nervous system disorder
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Hemizygous deletions of ERC1, FBXL14, or WNT5B genes may be involved in the development of neurological disorders in these individuals.
|
21144913 |
2011 |
Hepatitis C
|
0.010 |
Biomarker
|
disease |
BEFREE |
Taken together, these results suggest the possibility that NS3 plays a role in modulating host-cell functions such as intracellular transport and secretion through its binding to ELKS-delta and ELKS-alpha, which may facilitate the virus life cycle and/or mediate the pathogenesis of HCV.
|
16033967 |
2005 |
Neoplasms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
We identified one tumor as having an ELKS-RET rearrangement (1 of 105, 1%).
|
15876154 |
2005 |
Thyroid Neoplasm
|
0.010 |
Biomarker
|
disease |
LHGDN |
Differential expression of multiple isoforms of the ELKS mRNAs involved in a papillary thyroid carcinoma.
|
12203787 |
2002 |